eConsent

eConsent - Axcellant

eConsent

  1. Feb 28, 2025

What Does ‘eConsent’ Mean?

eConsent, short for electronic consent, refers to the process of obtaining informed consent from research participants using digital platforms or electronic devices. This method replaces traditional paper-based consent forms with interactive, multimedia presentations that can include text, graphics, audio, and video elements.

The eConsent process aims to enhance participant understanding of study information and improve the overall consent experience. It allows for more standardized consent procedures, easier tracking of participant engagement, and often provides the ability for participants to review materials at their own pace before making a decision.

Why Is the ‘eConsent’ Important in Clinical Research?

eConsent is crucial in clinical research as it modernizes and streamlines the informed consent process. It enhances participant comprehension through interactive multimedia elements, potentially leading to better-informed decisions and improved participant retention rates.

The importance of eConsent also lies in its ability to standardize consent procedures across multiple research sites and languages. This standardization, coupled with digital documentation and tracking capabilities, can significantly improve regulatory compliance and reduce administrative burdens in clinical trials.

Good Practices and Procedures

  1. Implement a user-friendly interface with adjustable font sizes and contrast options to accommodate participants with varying visual abilities
  2. Incorporate knowledge checks throughout the eConsent process to ensure participants comprehend key information before proceeding
  3. Utilize version control systems to manage and track changes in eConsent documents, ensuring all participants receive the most up-to-date information
  4. Integrate electronic signature capabilities that comply with 21 CFR Part 11 regulations for legally binding consent
  5. Provide a secure portal for participants to access their signed eConsent documents and related study information throughout the trial duration

Related Terms

Resources

Large Language Models in Nuclear Cardiology: From Experimental Tools to Clinical Infrastructure

3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…

From Half-Life to Clinical Impact: Mastering Time-Critical Supply Chains

How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…

How ACT EU Is Forcing a Global Approach to Trial Timelines

Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…